Practical Guidance on Storage, Reconstitution, Specifications and Custom Solutions for Global Researchers HUSTON, TX, ...
A new review synthesizes preclinical and clinical evidence showing that lipid nanoparticle biodistribution, mRNA persistence, ...
A new review from the University of Toronto charts the evolution of organosilane surface chemistry for biosensor probe ...
FLEETSTREET Magazine on MSN
The viral TikTok botox jelly that has everyone eating their skincare
No needles, no appointment: just gelatin, fruit and basil seeds. Here's what TikTok's "homemade Botox" actually is, what it ...
Zacks Small Cap Research on MSN
ARWR: Interim ARO-MAPT data shows potential for TRiM™ platform in CNS diseases
By David Bautz, PhD NASDAQ: ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Interim Data for ARO-MAPT Shows Promise ...
2d
If you can't use 'muscle repair,' how do you sell protein? I read the news and thought of some copy
I came across this news.It reports that Zushi City in Kanagawa Prefecture received administrative guidance for violating the ...
Explore KO/KD-validated antibodies that provide researchers with experimental evidence to assess antibody specificity ...
Arrowhead Pharmaceuticals, Inc. beats on ARO-MAPT with up to 85% CSF tau cut; CNS siRNA platform gains traction. Click for ...
Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers ...
A new review examines how protein and specific amino acid restriction may affect metabolism, cellular aging, and longevity, while highlighting important gaps in the human evidence.
Overlapping morphologic and immunophenotypic features between MCL and plasma cell neoplasms can complicate diagnosis.
Perspective Therapeutics announced FDA Fast Track Designation for PSV359 to treat advanced FAP-positive solitary fibrous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results